2seventy bio, Inc. - stock earnings

TSVT Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
May 1, 2024 BeforeMarket - / -0.7200000000 - - / 14.1 million -

TSVT Quarterly earnings

DateEarningsRevenue
2023Q4 -56.8 million USD 10.7 million USD
2023Q3 -71.6 million USD 12.0 million USD
2023Q2 -42.1 million USD 36.0 million USD
2023Q1 -42.5 million USD 41.6 million USD
2022Q4 -23.1 million USD 56.2 million USD
2022Q3 -67.4 million USD 13.4 million USD
2022Q2 -77.4 million USD 13.5 million USD
2022Q1 -80.9 million USD 8.4 million USD
2021Q4 -61.0 million USD 16.0 million USD
2021Q3 -60.0 million USD 19.3 million USD
2021Q2 -84.0 million USD 7.3 million USD
2021Q1 -87.2 million USD 11.9 million USD
2020Q4 -76.8 million USD 9.9 million USD
2020Q3 -72.1 million USD 18.4 million USD

TSVT Yearly earnings

DateEarningsRevenue
2023 -217.6 million USD 100.4 million USD
2022 -254.1 million USD 91.5 million USD
2021 -292.2 million USD 54.5 million USD
2020 -138.2 million USD 248.1 million USD
2019 -323.3 million USD 44.3 million USD
2018 -199.7 million USD 54.6 million USD

TSVT

Price: $4.59

52 week price:
1.54
12.69

Earnings Per Share: -4.42 USD

P/E Ratio: -1.59

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 673900

Market Capitalization: 252.5 million

Links: